Patent Oppositions in material property testing industry

Explore the competitive field of material property testing where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in material property testing technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the material property testing industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the material property testing industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 29, 2026STORZ
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026BRAND MURRAY FULLER
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 27, 2026GREINER
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 17, 2026POHLMAN
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 13, 2026MANZER
Bioprocess Purification System And MethodGE HEALTHCARE BIO SCIENCESJul 1, 2026NIERFELD
Improved Methods Of Assessing Gfap Status In Patient SamplesABBOTT LABORATORIESJun 26, 2026ARROWHOUSE
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026SK BIOSCIENCE
Compositions And Methods For Growth Factor ModulationSCHOLAR ROCKJun 16, 2026STRAWMAN
Apparatus And Method For Determining A Material Property Of A Test Specimen In A Test Specimen Region Near The SurfaceAIM SYSTEMSJun 3, 2026OPTISENSE GESELLSCHAFT FUR OPTISCHE PROZESSMESSTECHNIK

To stay ahead in the competitive material property testing industry, companies are constantly innovating. Here are the top patents facing oppositions in the material property testing industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 6, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Aug 24, 2022Compositions And Uses For Treating Multiple SclerosisBIOGEN MA17
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS15
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB11
Oct 29, 2025Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBB9
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY8
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECH6
Mar 28, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA6
Dec 21, 2022Identifying Patient Response To S1P Receptor Modulator AdministrationNOVARTIS5
Mar 21, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA5
Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO5